[Systemic sclerosis: pathophysiology of a multifaceted disease]

Area of Science:

• Rheumatology
• Immunology
• Cell Biology

Background:

• Systemic sclerosis is a rare autoimmune disease featuring vascular issues and collagen buildup.
• Abnormalities in fibroblasts, endothelial cells, and lymphocytes are hallmarks of systemic sclerosis.
• Key molecular pathways implicated include transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF).

Purpose of the Study:

• To elucidate the cellular and molecular mechanisms underlying systemic sclerosis.
• To investigate the role of oxidative stress and specific autoantibodies in disease pathogenesis.
• To understand the contribution of fibroblast and endothelial cell dysfunction to extracellular matrix accumulation.

Main Methods:

• Analysis of fibroblast activation pathways, including TGF-beta and CTGF.
• Assessment of endothelial cell function, apoptosis, and production of specific molecules like endothelin 1.
• Evaluation of oxidative stress markers and cytokine levels, such as interleukin 4.
• Detection and characterization of autoantibodies in patient serum.

Main Results:

• Fibroblast dysfunction involves overactive TGF-beta signaling and excess CTGF and free radical synthesis.
• Endothelial cells exhibit increased endothelin 1 and inducible NO synthase production, alongside premature apoptosis.
• Elevated levels of the profibrotic cytokine interleukin 4 are found in patients.
• Pathogenic autoantibodies targeting endothelial cells and fibroblasts are present in some patients.

Conclusions:

• Systemic sclerosis pathogenesis is significantly influenced by fibroblast and endothelial cell abnormalities.
• Oxidative stress plays a critical role in the progression of systemic sclerosis.
• Specific autoantibodies may contribute to the disease's vascular and cellular damage.
• Targeting these pathways and factors could offer therapeutic strategies for systemic sclerosis.